Bibliografías temáticas / Conference (1926 : Philadelphia, Pa.)

Literatura académica sobre el tema "Conference (1926 : Philadelphia, Pa.)"

Autor: Grafiati
Publicado: 26 de julio de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Índice

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Conference (1926 : Philadelphia, Pa.)".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Conference (1926 : Philadelphia, Pa.)"

1

O'Keefe, Thomas, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire et al. "Abstract PR008: Duration of endocrine treatment for DCIS impacts second events: Insights from a large registry of cases at two academic medical centers". Cancer Prevention Research 15, n.º 12_Supplement_1 (1 de diciembre de 2022): PR008. http://dx.doi.org/10.1158/1940-6215.dcis22-pr008.

Texto completo
Resumen
Abstract Background: Ductal carcinoma in situ (DCIS) incidence has risen with increasing use of screening mammography. It is unclear who benefits from both the amount and type of adjuvant treatment (radiation therapy, (RT), endocrine therapy (ET)) versus what constitutes over-treatment. Our goal was to identify the effects of adjuvant RT, or ET+/- RT versus breast conservation surgery (BCS) alone in a large multi-center DCIS registry of retrospective patients with long follow up. Methods: Data was extracted on women with a primary diagnosis of DCIS (N=2979) between 1985 - 2017 treated in 2 University of California (UC) medical centers. ET treatment and duration was confirmed by chart review for 1916 patients for this analysis. Receipt of ET (N=404) was stratified to > 2 years or < 2 years. Association between treatment type and second events was assessed using Cox regression. Competing risks models were used to assess effect of treatment type on different type of second events (ipsilateral DCIS or invasive, or contralateral combined). Time-varying coefficients were used as appropriate. Results: Median follow up time was 8.2 years for the 1916 patients analyzed. The cumulative second event (any type) rate was 25% at 15 years. In univariate and multivariate analysis adjusting for clinical variables, all treatments reduced the risk of second events compared to BCS only. Further stratifying ET receipt by duration demonstrated significant risk reduction (HR=0.12, P=0.04) only in women taking >2 years of ET, but not in women in the <2year ET group (HR=1.3, P=0.55). In the competing risk model, RT significantly reduces the risk of both ipsilateral DCIS and invasive cancer, and ET > 2 years significantly reduces the risk of ipsilateral invasive cancer. Conclusions: In our registry we show that women with DCIS who took less than 2 years of adjuvant endocrine therapy have a similar second event rate as BCS. In contrast, women who took more than 2 years of ET show a significantly reduced second event rate, similar to those who received either RT or combined ET+RT, which was independent of age, tumor size, grade, or period of diagnosis. This highlights the importance of ET duration for risk reduction of second events following surgery for newly diagnosed DCIS. Citation Format: Thomas O'Keefe, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire, Ann Griffin, Laura Esserman, Olivier Harismendy, Gillian Hirst. Duration of endocrine treatment for DCIS impacts second events: Insights from a large registry of cases at two academic medical centers [abstract]. In: Proceedings of the AACR Special Conference on Rethinking DCIS: An Opportunity for Prevention?; 2022 Sep 8-11; Philadelphia, PA. Philadelphia (PA): AACR; Can Prev Res 2022;15(12 Suppl_1): Abstract nr PR008.
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Smith, Randall S., Andrea Jewell, Evrosina Isaac y Jennifer M. Rohan. "Abstract B090: Relationship between medication adherence, psychosocial risk, and sociodemographic characteristics in pediatric cancer". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): B090. http://dx.doi.org/10.1158/1538-7755.disp22-b090.

Texto completo
Resumen
Abstract Background/Purpose: The purpose of this study is to examine the relationship between sociodemographic characteristics (e.g., minority status, geographic location), psychosocial risk, and medication adherence in pediatric cancer. Methods: This study included 40 pediatric oncology patients ages 2-19 years (Mage=11.6±5.6 years) in active treatment. 52.5% identified as non-Hispanic White, 32.5% identified as non-Hispanic minority, and 15% identified as Hispanic. Parents completed the Psychosocial Assessment Tool (PAT) at baseline assessing psychosocial risk factors. Patients used objective adherence monitors (MEMS) , which recorded daily adherence rates to chemotherapy and non-chemotherapy medications across one year. Results: The PAT identified that 55% of patients needed universal intervention and 45% needed targeted clinical interventions. Patients identified as lowest psychosocial risk (i.e., needing universal interventions), had significantly higher adherence rates (M=74%±22%) than those identified as highest psychosocial risk (i.e., needing targeted interventions; M=51%±37%; p < 0.004). While non-minoritized White patients demonstrated higher rates of treatment adherence (M=71%±32%) compared to minoritized patients (M=56%±31%); this finding was not significant. Additionally, there was no significant difference between geographic distance from hospital and medication adherence. In fact, those who lived closer to the hospital had lower adherence rates (M=62%±31%) compared to those who lived further away (M=67%±34%). There also was no significant difference between distance from hospital and psychosocial risk. Patients identified as greatest psychosocial risk (i.e., in need of targeted interventions) only lived 3 miles further from the hospital (M=27.1±26.6 miles) than those in need of preventative interventions (M=24.2±19.6 miles). Conclusions & Implications: The geographic location of pediatric oncology patients in relation to the hospital at which they received treatment did not significantly impact treatment adherence to chemotherapy and non-chemotherapy medications. Furthermore, minority status did not significantly affect treatment adherence rates. On the other hand, treatment adherence was significantly lower for patients whose parents reported more psychosocial stressors. Future research should identify innovative health promotion interventions targeting psychosocial risk, which seems to have the greatest influence on health behaviors like medication adherence. Citation Format: Randall S. Smith, Andrea Jewell, Evrosina Isaac, Jennifer M. Rohan. Relationship between medication adherence, psychosocial risk, and sociodemographic characteristics in pediatric cancer [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr B090.
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Carter, Brian J., Tzuan A. Chen, Dalnim Cho, Lorna H. McNeill, Shahnjayla K. Connors y Lorraine R. Reitzel. "Abstract A099: Black church-goers who most recently sought cancer information from certain sources are less likely to have ever undergone colorectal cancer screening and thus less likely to benefit from early detection". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): A099. http://dx.doi.org/10.1158/1538-7755.disp22-a099.

Texto completo
Resumen
Abstract Purpose: Black adults have the highest colorectal cancer (CRC) incidence and mortality rates of any racial group in America. Early detection through CRC screening may improve survival outcomes; however, CRC screening uptake is lower for Black adults than White adults. To uncover opportunities to address these inequities, we examine where Black adults prefer to obtain cancer information, where they most recently sought such information, and whether either was associated with CRC screening behavior. Methods: Participants were a convenience sample of Black men and women recruited from 3 churches in Houston, Texas. Self-reported data included preferred source of cancer information (doctor or health care provider (collectively, “providers”), cancer organization, social network, internet, or “other media” (i.e., books, brochures, pamphlets, the library, magazines, newspapers)), most recent source of cancer information (same categories as preferred), and having ever been screened for CRC. A logistic regression model controlling for recruitment site, sociodemographic variables (e.g., sex, education), personal and family history of cancer, worries and perceptions about cancer risk, and satisfaction with patient-provider communication examined associations between preferred and most recent source of cancer information, respectively, and CRC screening behavior. Results: The sample included 751 Black adults aged >50 (Mage=59.1+6.6, 24% male), with data collected before the pandemic. Overall, 57.9% of respondents indicated their preferred source of cancer information was a provider, 19.6% the internet, 11.5% other media, 10% a cancer organization, and 1.1% their social network. Overall, 21% indicated their most recent source of cancer information was a provider, 57.3% the internet, 13.5% other media, 4.7% a cancer organization, and 3.6% their social network. About 83.6% of participants had ever been screened for CRC. Results indicated that those who most recently sought information from other media had lower odds of having ever been screened for CRC than those who most recently sought information from a provider (aOR: 0.489, CI95%: 0.245-0.976). There were no significant associations between preferred source of cancer information and CRC screening behavior. Conclusion: These results reveal an opportunity to encourage Black church-goers to obtain cancer information from providers rather than from other media as a method to enhance CRC screening use. Encouragement to seek this information directly from a provider could, for example, come from health ministries, church newsletter or email communications, the church’s website, and/or the pulpit. These results also reveal an opportunity to investigate what modifiable social determinants or other factors prevent Black church-goers from seeking cancer screening information from their provider as opposed to other media, especially considering most of the sample preferred to get this information from a provider, as one part of a multi-pronged approach to help mitigate racial inequities in CRC screening behavior. Citation Format: Brian J. Carter, Tzuan A. Chen, Dalnim Cho, Lorna H. McNeill, Shahnjayla K. Connors, Lorraine R. Reitzel. Black church-goers who most recently sought cancer information from certain sources are less likely to have ever undergone colorectal cancer screening and thus less likely to benefit from early detection [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr A099.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Lalonde, Chloe S., Jeffrey M. Switchenko, Madhusmita Behera, Mehmet A. Bilen, Taofeek K. Owonikoko, Colleen M. Lewis, Elise Hitron et al. "Abstract B085: Shifting sociodemographic characteristics of a phase 1 oncology clinical trial population at an NCI-designated Comprehensive Cancer Center in the Southeast in comparison to its catchment area". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): B085. http://dx.doi.org/10.1158/1538-7755.disp22-b085.

Texto completo
Resumen
Abstract Background: Racial and ethnic minority populations are consistently under-represented in oncology clinical trials despite comprising a disproportionate share of cancer burden. Due in part to difficulties associated with participation, phase 1 (P1) oncology trials pose a unique challenge and opportunity for minority inclusion. Here we examine the sociodemographics of P1 cancer clinical trial patients at an NCI-designated Comprehensive Cancer Center compared to all patients treated at the center, patients with new cancer diagnoses in metropolitan Atlanta (ATL), and the state of Georgia (GA). Methods: Patients enrolled on P1 trials at the Winship Cancer Institute (WCI) from 2015- 2020, identified from a data warehouse, were compared to new patient registrations at WCI from 2015-2020. Patients with cancer in metro ATL and GA were identified from the SEER Nov 2018 Submission. Covariates for the P1 and WCI institutional cohorts included sex, race, insurance, zip code. Covariates for SEER patients included sex and race. Median income by zip code per Census 2020 data was divided in quartiles per Census 2020 GA income distribution. Summary statistics are reported for categorical variables using frequencies and percentages. Comparisons between groups were conducted using one-sample proportion tests. Trends were assessed using the Cochran-Armitage test. Results: From 2015-2020, 2325 patients (43.4% F, 56.6% M) signed consent for P1 trials. Grouped race distribution was 70.3% White, 26.2% Black, 3.5% Other. Insurance distribution was 42.9% private, 48% government, 9.1% uninsured/other. Of new patient registrations at WCI from 2015-2020 (N=107497) (50.0% F, 50.0% M), grouped race distribution was 63.3% W, 32.0% B, 4.7% O. ATL 2015 SEER patients (N=31101) (50.3%F, 49.7%M) showed grouped race distribution 58.4% W, 37.2% B, 4.3% O. GA 2015 SEER patients (N=99487) (48.6%F, 51.4%M) showed grouped race distribution 71.2% W, 26.7% B, 2.1% O. Race and sex distribution of P1 patients was significantly different than WCI and ATL SEER patients (p< 0.001). Comparing the P1 and WCI groups from 2015-2020, percent female did not change over time in either group (p=0.54 P1; p=0.063 WCI). Percentage of white patients did decrease over time in both groups (p=0.009 P1; p<0.001 WCI). Percent of P1 patients with private insurance was higher than the WCI group (p<0.001). Percent of P1 and WCI patients living in zip codes with lower median household income (Q1 & Q2) were 19.6% and 20.4%, respectively (p=0.41). Conclusions: Although P1 patients at WCI were more likely to be white, male, and privately insured, from 2015-2020, the percentage of white patients in P1 oncology clinical trials and amongst all new cancer patients treated at WCI decreased significantly. This data serves to initially characterize the existing racial disparities in oncology clinical trials in metro ATL and GA, and will lead to further understanding to ultimately improve representation of patients from racial and ethnic minority backgrounds in P1 clinical trials in our catchment area. Citation Format: Chloe S. Lalonde, Jeffrey M. Switchenko, Madhusmita Behera, Mehmet A. Bilen, Taofeek K. Owonikoko, Colleen M. Lewis, Elise Hitron, Hannah Collins, Tracy B. Goodale, Emma C. Judson, Ludimila Cavalcante, R. Donald Harvey, Jennifer W. Carlisle. Shifting sociodemographic characteristics of a phase 1 oncology clinical trial population at an NCI-designated Comprehensive Cancer Center in the Southeast in comparison to its catchment area [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr B085.
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Telles, Victoria M., Mateo Banegas y David Strong. "Abstract B131: Social drivers of adverse health outcomes among cancer survivors". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 12_Supplement (1 de diciembre de 2023): B131. http://dx.doi.org/10.1158/1538-7755.disp23-b131.

Texto completo
Resumen
Abstract Purpose of the Study Disparities in health outcomes among cancer survivors are often driven by differences in social-ecological resources. Poor health outcomes and multiple chronic conditions often manifest as a result of shared demographic and social risk factors. The aim of this study was to examine the social drivers that predict adverse health outcomes among cancer survivors. Methods Data from the national longitudinal Population Assessment of Tobacco and Health (PATH) Study was used to examine social drivers of several adverse health outcomes: tobacco use, sleep trouble, high cholesterol, diabetes, and high blood pressure among cancer survivors enrolled in the first cohort (waves 1-3; n=1924). Social drivers included education, financial stress, poverty level, insurance status, and satisfaction with social relationships. Survey-weighted multivariable logistic regression was used to assess demographic and social drivers that predicted health outcomes among cancer survivors. Results Among the 1,924 cancer survivors, most were non-Hispanic, White (77%); 56% female; ages ranged from 18-34 (14%), 35-54 (27%), 55-64 (24%), 65+ (34%). Higher tobacco use was linked (p’s<0.05) to both demographic (males, younger) and social drivers (lower education, poverty, lack of insurance and social dissatisfaction). Trouble sleeping was associated with social drivers including financial stress (p<.001) and social dissatisfaction (p<.0001). High cholesterol was significantly associated with demographics (older age) and social drivers including lower education, access to insurance, and social dissatisfaction (p’s<.05). High blood sugar was significantly associated with demographics (older age, NH Black) and social drivers (lower education and social dissatisfaction (p’s<.05). High blood pressure was significantly associated with demographic (older age, male, NH Black) and social drivers including lower education college (p<.05) and financial stress (p<.05). Conclusions Increased recognition of the critical role of social drivers on health outcomes suggests effective interventions that are sensitive to cancer survivors’ social-ecological contexts are needed to improve health equity and reduce cancer health disparities. Citation Format: Victoria M. Telles, Mateo Banegas, David Strong. Social drivers of adverse health outcomes among cancer survivors [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl):Abstract nr B131.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Vasthu, Durango. "Global Supply Chain Management Conference". International Journal of Risk and Contingency Management 1, n.º 1 (enero de 2012): 64–65. http://dx.doi.org/10.4018/ijrcm.2012010105.

Texto completo
Resumen
The 2011 annual ‘big event’ in the global supply chain industry was held in Philadelphia PA USA during the week of October 2-5. This event is organized each year, and is the official global meeting, for the Council of Supply Chain Management Professionals (CSCMP, http://cscmp.org/events/annual-global/sessionsearch-after.asp). The conference featured risk-related topics ranging from inventory forecasting to reverse logistics planning in globally-impacted markets.
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Johnson, Wenora Y. "Abstract IA002: How patient advocates can make a difference in their research advocacy efforts and contributions and why it's important". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): IA002. http://dx.doi.org/10.1158/1538-7755.disp22-ia002.

Texto completo
Resumen
Abstract Knowledge about cancer research has driven me to advocate on behalf of myself and others who need to know about their cancer risk, hereditary pre-disposition, prevention and survivorship. Understanding how Patient Advocates can make a difference is extremely important and valuable to research. Citation Format: Wenora Y. Johnson. How patient advocates can make a difference in their research advocacy efforts and contributions and why it's important [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl):Abstract nr IA002.
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Drage, Michael G. "Abstract IA005: Artificial intelligence for breast pathology: Challenges and opportunities (and more challenges!)". Cancer Prevention Research 15, n.º 12_Supplement_1 (1 de diciembre de 2022): IA005. http://dx.doi.org/10.1158/1940-6215.dcis22-ia005.

Texto completo
Resumen
Abstract This presentation will review some fundamental aspects of breast pathology, introduce PathAI’s approach to building algorithms for computer vision applications, and highlight some applications where AI has shown capacity to yield clinically-relevant insights from breast cancer specimens. I will also highlight some interesting challenges in breast pathology practice pertinent to intraductal proliferations, and how these challenges are beginning to be addressed in the field of AI. Citation Format: Michael G. Drage. Artificial intelligence for breast pathology: Challenges and opportunities (and more challenges!) [abstract]. In: Proceedings of the AACR Special Conference on Rethinking DCIS: An Opportunity for Prevention?; 2022 Sep 8-11; Philadelphia, PA. Philadelphia (PA): AACR; Can Prev Res 2022;15(12 Suppl_1): Abstract nr IA005.
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Ashour, Ahmed M., Amro M. Al-Omari, Mohammad S. Bani Amer y Zaid R. Kamal. "Abstract A010: Insights into the Impact of Fanconi Anemia Repair Genes on Immunotherapy Response in Solid Tumors". Cancer Research 84, n.º 1_Supplement (9 de enero de 2024): A010. http://dx.doi.org/10.1158/1538-7445.dnarepair24-a010.

Texto completo
Resumen
Abstract Title: Insights into the Impact of Fanconi Anemia Repair Genes on Immunotherapy Response in Solid Tumors Background: Fanconi anemia repair (FAR) genes have crucial involvement in determining immunogenicity of solid tumors due to their substantial involvement in DNA damage repair (DDR). Previous work has alluded to the significance of DDR pathways such as mismatch repair and homologous recombination genes in treatment guidance. Herein, we study the potential impact of FAR genes mutations on immunotherapy parameters in solid tumors. Methods: We used the MSK immunotherapy and Tumor Mutational Burden (TMB) dataset was used in our analysis, which includes mutational and clinical data for 1661 patients on immune checkpoint inhibitors (anti-PD-1/L1, anti-CTLA-4, or combinational therapy) from ten cancer types (bladder, breast, colorectal, esophagogastric, glioma, head and neck, melanoma, non- small cell lung, renal cell, and unknown primary cancer). All clinical ang genomic data was retrieved through the cBioPortal database. Patients were categorized into the FAR mutated group if they harbored a mutation in at least one of the FAR genes (FANCA, FANCC, BRCA2, BRIP1, PALB2, RAD51C, SLX4) included in the MSK-IMPACT targeted next-generation sequencing panel. The log rank test and the Wilcoxon test, Chi-squared test were used to compare overall survival (OS), continuous and categorical data between FAR mutated and wildtype groups. Results: The MSK TMB cohort included 220 (13%) patients with FAR mutations, of which melanoma comprised the highest percentage (26.4%) followed by non-small cell lung cancer (NSCLC; 19.6%). The most common altered FAR gene was BRCA2 (6%), followed by SLX4 (5%), while the least altered gene was RAD51C (0.7%). FAR mutated patients had significantly higher OS compared to the wildtype group (median OS (mOS): 29 vs 17 months, log rank p < 0.001). Among melanoma patients (n = 320), there was no significant difference in OS between the mutated and FAR groups, whereas the NSCLC (n = 350) and colorectal cancer (CRC, n = 110) subgroups had significantly higher OS in the FAR mutated groups (NSCLC - mOS: 19 vs 10 months, p = 0.0256, CRC – mOS: not reached vs 13 months, p &l; 0.001). TMB was significantly higher in the FAR mutated group (median TMB: 22.3 vs 5.2, p < 0.001). Notably, the most frequent co-mutations in the FAR mutated group included CTLA4, STK19, E2F3, CD276, MYCL. Conclusion: Our analysis highlights the potential role of FAR genes mutations in predisposing solid tumor patients to ICI benefit, specifically in NSCLC and CRC patients. Insights into the potential interactions between FAR genes and other DDR pathways as well as their impact on tumor immune microenvironment parameters are needed in future research to understand the drivers of ICI benefit in this subset of patients. Citation Format: Ahmed M. Ashour, Amro M. Al-Omari, Mohammad S. Bani Amer, Zaid R. Kamal. Insights into the Impact of Fanconi Anemia Repair Genes on Immunotherapy Response in Solid Tumors [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: DNA Damage Repair: From Basic Science to Future Clinical Application; 2024 Jan 9-11; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2024;84(1 Suppl):Abstract nr A010.
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Sharma, Hari, Stephen Skaper y Aruna Sharma. "Conference Report: 7th Clinical Trials on Alzheimer’s Disease Annual Conference, Philadelphia, PA, USA Nov 20-22, 2014". CNS & Neurological Disorders - Drug Targets 14, n.º 1 (1 de febrero de 2015): 7–10. http://dx.doi.org/10.2174/1871527314666150130155536.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Libros sobre el tema "Conference (1926 : Philadelphia, Pa.)"

1

ACM, Computer Science Conference (24th 1996 Philadelphia Pa ). Proceedings, 1996 ACM Computer Science Conference: Philadelphia, PA, February 16-18, 1996. New York: Association for Computing Machinery, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Philadelphia), National Conference on Artificial Intelligence (5th 1986. Proceedings AAAI-86: Fifth National Conference on ArtificialIntelligence : August 11-15 1986, Philadelphia, Pa.. Los Altos: William Kaufmann, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

National Conference on Artificial Intelligence (5th 1986 Philadelphia). Proceedings AAAI-86: Fifth National Conference on ArtificialIntelligence : August 11-15 1986, Philadelphia, Pa.. Los Altos: William Kaufmann, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

CLE Administrators' Seminar (1986 Philadelphia, Pa.). CLE Administrators' Seminar: April 7-8, 1986, ALI-ABA Conference Center, 4025 Chestnut Street, Philadelphia, PA. [Philadelphia, PA] (4025 Chestnut St., Philadelphia 19104): American Law Institute-American Bar Association, Committee on Continuing Professional Education, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Joint ASME/ANS Nuclear Power Conference (1986 Philadelphia, Pa.). Proceedings of the 1986 Joint ASME/ANS Nuclear Power Conference, July 20 to July 23, 1986, Philadelphia, Pa. La Grange Park, Ill., USA: American Nuclear Society, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

ACM SIGPLAN Conference on Programming Language Design and Implementation (1996 Philadelphia, Pa.). Proceedings of the ACM SIGPLAN '96 Conference on Programming Language Design and Implementation (PLDI): Philadelphia, PA, May 21-24, 1996. New York N.Y: Association for Computing Machinery, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

American Italian Historical Association. Conference. Italian Americans : the search for a usable past: Proceedings of the 19th annual conference of the American Italian Historical Association, Philadelphia, Pa., November 14-15, 1986. Editado por Cannistraro Philip V. 1942-, Juliani Richard N, American Italian Historical Association y Paul Avrich Collection (Library of Congress). Staten Island, N.Y: The Association, 1986.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

American Italian Historical Association. Conference. Italian Americans: The search for a usable past : proceedings of the 19th annual conference of the American Italian Historical Association Philadelphia, Pa., November 14-15, 1986. Editado por Juliani Richard N, Cannistraro Philip V. 1942- y American Italian Historical Association. Staten Island, N.Y: The Association, 1989.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Workshop on I/O in Parallel and Distributed Systems (4th 1996 Philadelphia, Pa.). Proceedings of the IOPADS, Fourth Annual Workshop on I/O in Parallel and Distributed Systems: Part of the Federated Computing Research Conference, May 27, 1996, Philadelphia, PA. New York: Association for Computing Machinery, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Ristine, James D. Philadelphia's 1926 sesqui-centennial international exposition. Charleston, SC: Arcadia Pub., 2009.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Conference (1926 : Philadelphia, Pa.)"

1

"GR OUNDWATER REMEDIATION SYSTEM FOR THE RUNWAY 8-26 DEVELOPMENT PROJECT: PHILADELPHIA INTERNATIONAL AIRPORT, PHILADELPHIA, PA". En Hazardous and Industrial Waste Proceedings, 30th Mid-Atlantic Conference, 909. CRC Press, 2014. http://dx.doi.org/10.1201/9781498709453-147.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Conference (1926 : Philadelphia, Pa.)"

1

Guo, Sheng, Wubin Qian, Jie Cai, Jean-Pierre Wery y Henry Qixiang Li. "Abstract 1926: Patient-derived xenografts seem to have closer global expression profile to that of the patient tumors of the corresponding cancer types, than the equivalent cell lines do". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-1926.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Kordas, Camille, Joshua Li, Kristin Ferrer, Yi Shan Jin, Nathaly Manrique, Min Seo Kang, Joon Seo et al. "Abstract 1926: Selective induction of apoptosis by aqueous extract of Chinese medicinal herbsScutellaria barbataandOldenlandia diffusainHCT 116 colon cancer cells and CCD 841 CoN colon epithelial cells". En Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1926.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Marano, Daniel P. "Foundation Design Case Study—Comcast Technology Center, Philadelphia, PA". En Eighth International Conference on Case Histories in Geotechnical Engineering. Reston, VA: American Society of Civil Engineers, 2019. http://dx.doi.org/10.1061/9780784482094.018.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Ashraf, O., H. Rovnan, M. Young, K. Yarlagadda, K. J. Malik y T. J. Cheema. "Expect the Unexpected: Pulmonary and Disseminated Blastomycosis in Pittsburgh, PA". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6942.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Puga, Lisa. "“Homeschooling is our Protest:” Educational Liberation for African American Homeschooling Families in Philadelphia, PA". En 6TH INTERNATIONAL CONFERENCE ON THE GEOGRAPHIES OF CHILDREN, YOUTH AND FAMILIES. Galoa, 2019. http://dx.doi.org/10.17648/gcyf-2019-99433.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Sleiman, P., M. Behr, C. Lott, C. Qiu, N. Galagedera, B. Sinder, J. Anari, P. Cahill y H. Hakonarson. "Genetic Analysis of a Thoracic Insufficiency Syndrome Cohort from the Children's Hospital of Philadelphia". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5666.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Ebbert, K., S. Evans, M. Al-Teneiji, J. Corbeil, L. Fairservice, K. Mak, A. Sagasser et al. "Pediatric Cystic Fibrosis Post-Clinic Conference Framework". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5322.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Dodia, N., D. Amariei, S. E. Hines, A. Burke, J. R. Galvin y N. W. Todd. "Multidisciplinary Conference Provides Diagnostic Clarity in Interstitial Lung Disease". En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3360.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Carlos, W. G., A. Gallo de Moraes, V. Kaul, D. Khateeb, S. R. Kudchadkar, L. Santhosh, N. H. Stewart, L. Swamy, G. Winter y C. L. Carroll. "Who Is Influencing the ATS International Conference on Twitter?" En American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1443.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Uzzi, Mudia y Lorraine Dean. "213 Credit scores as a novel measurement tool to examine violence inequities in Philadelphia, PA". En Society for the Advancement of Violence and Injury Research (SAVIR) 2020 conference abstracts. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/injuryprev-2020-savir.133.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Informes sobre el tema "Conference (1926 : Philadelphia, Pa.)"

1

Iberall, Thea y S. T. Venkataraman. Workshop on Dextrous Robot Hands: IEEE International Conference on Robotics and Automation. Held in Philadelphia, PA April 25-29, 1988. Fort Belvoir, VA: Defense Technical Information Center, abril de 1988. http://dx.doi.org/10.21236/ada203788.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Conference (1926 : Philadelphia, Pa.)" para tipos de fuentes particulares:
Artículos de revistas Libros
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía